A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients

This publication has 17 references indexed in Scilit:

• Evaluation of Limited Sampling Strategies for Estimation of 12-Hour Mycophenolic Acid Area Under the Plasma Concentration???Time Curve in Adult Renal Transplant Patients
  Therapeutic Drug Monitoring, 2000
• The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients
  Clinical Pharmacology & Therapeutics, 1999
• A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1
  Transplantation, 1999
• The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*
  Clinical Pharmacology & Therapeutics, 1998
• Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation
  Transplantation Proceedings, 1998
• Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection
  Clinical Biochemistry, 1998
• Limited Sampling Strategy for the Determination of Mycophenolic Acid Area Under the Curve in Pediatric Kidney Recipients
  Transplantation Proceedings, 1998
• A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
  Transplantation, 1996
• Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
  The Lancet, 1995
• Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation
  Clinical Pharmacology & Therapeutics, 1993